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ABSTRACT
ADP-ribosyltransferases (ARTs) are important
enzymes that regulate the genotoxic stress
response and the maintenance of genome integrity.
ARTD1 (PARP1) and ARTD2 (PARP2) are homologous
proteins that modify themselves and target proteins
by the addition of mono- and poly-ADP-ribose (PAR)
moieties. Both enzymes have been described to be
involved in the genotoxic stress response. Here, we
characterize cellular PAR formation on hydrogen
peroxide (H2O2) or N-methyl-N
0-methyl-nitro-N-
nitrosoguanidine (MNNG) stress, in combination
with application of the RNA polymerase I inhibitor
Actinomycin D (ActD), known to cause accumulation
of short RNA polymerase I-dependent rRNA
transcripts. Intriguingly, co-treatment with ActD
substantially increased H2O2- or MNNG-induced
PAR formation. In cells, this enhancement was
predominantly mediated by ARTD2 and not ARTD1.
In vitro experiments confirmed that ARTD2 is
strongly activated by RNA and that the N-terminal
SAP domain is important for the binding to RNA.
Thus, our findings identify a new activator of
ARTD2-dependent ADP-ribosylation, which has
important implications for the future analysis of the
biological role of ARTD2 in the nucleus.
INTRODUCTION
Cells have evolved a complex and diverse arsenal of
mechanisms to overcome genotoxic stress and to guaran-
tee genome integrity (1). Depending on the type of stress,
different response mechanisms are activated to repair
damaged DNA or to prevent its inheritance (2,3). In
addition to factors that directly bind and replace incorrect
bases and repair DNA strand breaks, a variety of proteins
are indirectly involved in the genotoxic stress response by
regulating the levels and activities of other proteins or by
modulating chromatin structure. ADP-ribosyltransferases
(ARTs) are prominent members of this group of enzymes.
ARTs use nicotinamide adenine dinucleotide (NAD+)
as a substrate for the synthesis of mono- and poly-
ADP-ribose modiﬁcations on target proteins (4). The
ART protein family is divided into diphtheria toxin-like
ARTs (ARTDs) and cholera toxin-like ARTs (ARTCs)
(5). In humans, the ARTD (PARP) family currently
comprises 18 nuclear and cytoplasmic mono- and poly-
ARTs, while ARTCs are mainly extracellular enzymes
that only transfer a single ADP-ribose unit to their
target proteins (5).
Proteins of the ARTD family have been implicated in a
plethora of cellular functions (6,7). Research during the
past years has documented numerous functions of
ARTD1 (PARP1) and of ADP-ribosylation in general
that are not directly linked to DNA repair or the DNA
damage response (8,9). The function of ARTD1 in DNA
repair is substantiated by the strong activation of ARTD1
activity by DNA in vitro, as well as by the strong induction
of poly-ADP-ribosylation on treatment of cells with
DNA-damaging agents. Nevertheless, a direct involve-
ment of DNA damage in the activation of ARTD1
in vivo is still largely based on correlations. PAR forma-
tion is dependent on the severity of the genotoxic stress
and can even lead to cell death due to depletion of NAD+
and ATP (10). The functional involvement of ADP-
ribosylation in the DNA damage response has provided
the incentive to generate PARP inhibitors as antitumor
drugs, which are being developed and tested as novel
therapies (11–14). The closest homolog of ARTD1 is
ARTD2 (PARP2), which too is able to mono- and poly-
ADP-ribosylate itself in addition to target proteins.
Although ARTD1 has already been discovered several
decades ago, ARTD2 was coincidentally discovered
much later in the 1990s because of the detection of
residual PAR-forming activity in mouse embryonic ﬁbro-
blasts (MEFs) from ARTD1 knockout mice (15). Like
ARTD1, ARTD2 has also been implicated in various
cellular functions, which include genome and chromosome
stability, heterochromatin integrity, cell death, differenti-
ation and inﬂammation (16). Mammalian ARTD2 is a
66.2-kDA protein with a C-terminal catalytic domain
that is 69% similar to the homologous domain in
ARTD1 (15,17). Despite this common domain, ARTD2
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is catalytically much less active than ARTD1, suggesting
that ARTD2 may become activated by different and as yet
unknown stimuli. While the DNA binding domain of
ARTD1 contains two Zn ﬁngers and a Zn-binding
domain, the DNA binding element of ARTD2 is repre-
sented by the SAF-A/B, Acinus and PIAS DNA-binding
(SAP) domain. Furthermore, ARTD2 seems to modify
different proteins, suggesting that both enzymes might
regulate distinct biological functions (18,19). Thus, the
identiﬁcation of such new ARTD2 activators will likely
also reveal novel biological phenomena that are regulated
speciﬁcally by ARTD2.
Nucleoli are sites of ribosomal RNA (rRNA) gene tran-
scription, rRNA maturation and ribosome production,
and assemble around the nucleolar organizer regions
(20,21). A human diploid cell contains 400 rRNA
genes, which are all organized in head-to-tail tandem
repeats on ﬁve different chromosomes (21). However, as
in highly metabolically active cells, only a subset of these
genes is actively transcribed (22,23). The remaining rRNA
genes are silenced in a tissue- and cell type-speciﬁc manner
(24). Active rRNA genes are transcribed by RNA poly-
merase I (Pol I) to synthesize a 45S pre-rRNA. For the
initiation of rRNA transcription, Pol I has to be part of a
multi-protein complex that includes factors such as UBF,
SL1 and TIF-IA (25). The production of ribosome
subunits is heavily inﬂuenced by diverse stress stimuli
and metabolic changes (26). The cell reacts to nutrient
starvation, oxidative stress or inhibition of protein synthe-
sis with a decrease of rRNA transcription, whereas growth
factors and proliferation-stimulating agents increase
rRNA transcription. Actinomycin D (ActD) inhibits
rRNA synthesis already at low concentrations (50 ng/
ml), whereas RNA polymerases II (Pol II) and III (Pol
III) are inhibited only at higher concentrations (Pol
II> 1 mg/ml, Pol III> 5 mg/ml) (27,28). ActD intercalates
into CG-rich regions of the DNA, and thus stabilizes
covalent topoisomerase I-DNA complexes, preventing
progression of RNA polymerase, thereby inhibiting
RNA synthesis (29). The intercalation mainly takes
place downstream of rDNA transcription start sites,
thus inhibiting transcription during elongation, which
leads to an immense accumulation of short RNA
transcripts over time (30,31). In Drosophila, ARTD1 has
been reported to regulate ribosomal biogenesis at the
posttranscriptional pre-rRNA processing level (32).
Furthermore, ARTD1 and ARTD2 have both been
shown to co-localize with B23/nucleophosmin and
nucleolin, nucleolar proteins involved in several processes
including rRNA transcription and elongation, ribosome
assembly and rRNA processing (33,34). However, no
direct effect of ARTD1 and ARTD2 on Pol I
transcription was described in these studies. More
recently, ARTD1 has been linked to heterochromatin
formation, speciﬁcally to silencing of rRNA genes in the
nucleolus (35,36).
Here, we characterize the nucleolar function of ARTD2
on different stresses. Hydrogen peroxide (H2O2) or
N-methyl-N’-methyl-nitro-N-nitrosoguanidine (MNNG)
treatment of different cell lines induced PAR formation
in the nucleolus. Co-treatment with low doses of ActD
enhanced PAR formation. Surprisingly, this co-treatment
mainly activated ARTD2. In vitro experiments conﬁrmed
that ARTD2 is strongly activated by short rRNA and
other single-stranded RNAs, but not by double-stranded
DNA, through its SAP domain. Thus, our ﬁndings reveal
a new activator of ARTD2, which opens new possible
implications for the future analysis of the biological role
of ARTD2.
MATERIALS AND METHODS
Cell culture
T24 bladder tumor cells were cultivated in McCoy’s 5A
medium (Gibco, Invitrogen, CA, USA) at 37C. NIH/
3T3, HeLa cells and MEFs were cultivated in
Dulbecco’s modiﬁed Eagle’s medium (PAA, Pasching,
Austria). MD-MBA-231 cells were cultivated in Roswell
Park Memorial Institute medium (Gibco, Invitrogen, CA,
USA). All media were supplemented with 1% (v/v)
Penicillin/Streptomycin and 10% (v/v) fetal calf serum
(Gibco, Invitrogen, CA, USA).
siRNA transfection
Negative control allstars (siMock), human siPARP1
(SI02662996), human siPARP2 (SI02664725), human
siPARG (SI00677782), mouse siPARP1 (SI02731428)
and mouse siPARP2 (SI02735670) were all obtained
from Qiagen (Hilden, Germany). Cells were seeded 1
day before transfection (5 105 cells per 6 cm plate) and
transfected with 40 nmol siRNA per plate and RNAi
MAX lipofectamine (Invitrogen, Carlsbad, CA, USA).
Antibodies
The following antibodies were used: from Santa Cruz
Biotechnology, Inc (Dallas, TX, USA): PARP1/ARTD1
(H-250, sc-7150, rabbit), Pol I (RPA 194, H-300, sc-28714,
rabbit). From Active motif (Carlsbad, CA, USA): PARP2
(39744, rabbit). From Sigma Aldrich (St. Louis, MO,
USA): tubulin (T6199, mouse). From Cell Signaling
(Danvers, MA, USA): ﬁbrillarin (C13C3). From Merck-
Millipore (Billerica, MA, USA): phosphor-Histone
H2A.X (Ser139). From Jackson ImmunoResearch
Laboratories (Suffolk, UK): secondary FITC-conjugated
AfﬁniPure goat anti-mouse, secondary Cy3TM -
conjugated AfﬁniPure goat anti-mouse. From Invitrogen
(Gibco, Invitrogen, CA, USA): Alexa-Fluor 488 anti-
rabbit IgG (A11008). The antibody 10H anti-PAR was
used to identify PAR by immunoﬂuorescence (IF).
RNA analysis
RNA was puriﬁed using TRIzol RNA Isolation Reagent
(500ml, Life Technologies, CA, USA) and reverse
transcribed according to the supplier’s protocol (High
Capacity cDNA Reverse Transcription Kit, Applied
Biosystems, Foster City, CA, USA). Quantitative real-
time polymerase chain reactions (qPCR) were performed
with SYBR green SensiMix SYBR Hi-ROX Kit (Bioline
Reagents Ltd., London, UK) and a Rotor-Gene Q 2plex
HRM System (Qiagen, Hilden, Germany).
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Cell lysis, sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and western blot analysis
Whole cell lysis was performed either with trypsinized cells
or directly on plates by using RIPA lysis buffer (50mM
Tris, pH 8, 400mM NaCl, 0.5% NP40, 1% DOC, 0.1%
SDS, 1 mg/ml pepstatin, 1 mg/ml bestatin, 1 mg/ml
leupeptin, 2mM PMSF, 10mM b-Glycerophosphate,
1mM NaF and 1mM dithiothreitol; 10min, 4C).
Proteins were quantiﬁed using the Lowry assay and, if
not otherwise indicated, 30 mg of protein extract was
loaded and separated on a 10 or 12% SDS-polyacrylamide
gel (120V, 2 h). The gel was blotted on a polyvinylidene
diﬂuoride membrane and analysed by using protein
speciﬁc antibodies.
Immunoﬂuorescence microscopy
Cells were seeded on coverslips (105 cells per well in a
24-well-plate) and grown overnight. After H2O2 (1mM
in FCS-free medium, 10min), MNNG (500 mM in FCS-
free medium, 30min) or medium-only treatment, cells
were ﬁxed (methanol: acetic acid 3:1, 5min on ice),
washed twice with phosphate buffered saline (PBS) and
incubated with antibody (1:350) in PBS (containing 5%
milk and 0.05% Tween, 1 h at room temperature or over-
night at 4C). When indicated, 4% PFA was used as
ﬁxation method (15min, room temperature). Cells were
then incubated with antibody for 1 h at room temperature.
After washing with PBS, coverslips were mounted with
Vectashield containing 40,6-diamidino-2-phenylindole
(DAPI; Vector Laboratories, Burlingame, CA, USA).
Conventional microscopy was carried out using a Leica
DMI 6000B light microscope (Leica microsystems GmbH,
Wetzlar, Germany). Confocal laser scanning microscopy
was carried out with a Leica SP 5 resonant APD system
(Leica microsystems GmbH, Wetzlar, Germany).
The mean PAR signal intensity per cell was quantiﬁed
with ImageJ (37) in at least 100 cells per replicate. The
color threshold was set for Max entropy and B&W.
According to the intensity of the picture, the threshold
was set for each experiment the same way; thus, different
replicates were comparable with each other.
Co-localization was quantiﬁed with Imaris (Bitplane,
Belfast, UK) using the co-loc application. The thresholds
were set for all three channels (DAPI, blue; PAR, red; and
ﬁbrillarin, green) and kept for the whole analysis. At least
50 cells were analyzed for H2O2 treated samples (from
three biological replicates) and at least 25 cells were
analyzed for H2O2 ActD treated samples (from two bio-
logical replicates).
In vitro RNA transcription
Linearized vectors containing rRNA sequences (mouse
rRNA from 16 to +130 and 232 to 1) and control
sequences (36) were used to in vitro transcribe RNA using
T7 polymerase. After DNase I treatment, transcripts were
double puriﬁed using TRIzol reagent (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s
protocol.
In vitro ARDT1 or ARTD2 activity assay
Ten picomoles of baculovirus-puriﬁed MYC-
hARTD1(wt)-HIS or puriﬁed human ARTD2(ﬂ)-HIS
was incubated with NAD+ in the reaction buffer
(250mM Tris–HCl, pH 8, 20mM MgCl2, 1.25mM
dithiothreitol, 5 mg/ml P/B/L–proteinase inhibitors, 30C,
10min). Five picomoles of EcoRI linker DNA or different
concentrations as indicated of short RNA transcripts were
added to the reaction. For ADP-ribosylation reactions,
radioactive NAD+ (32P, ﬁnal concentration 100 nM) and
nonradioactive NAD+ (ﬁnal concentration 1.6 or 16 mM)
were added. Reactions were terminated by adding
Laemmli buffer and subsequent boiling of the samples
(5min, 95C). SDS-PAGE was performed; gels were
stained with coomassie, destained and subjected to ﬁlm
exposure. The autoradiography was quantiﬁed with the
software GelEval (http://www.frogdance.dundee.ac.uk/).
In vitro poly-ADP-ribose-glycohydrolase (PARG) assay
ARTD1 auto-ADP-ribosylation was carried out as
described before and the reaction mix was puriﬁed over
illustra MicroSpin G-50 Columns (GE Healthcare GmbH
Europe, Freiburg, Germany). Equal amounts of reaction
mix were added to prechilled tubes containing baculo-
puriﬁed hPARG-(ﬂ) (2 pmol). Reactions were carried
out in the presence or absence of the indicated molecules.
Nothern blot and Northwestern analysis
Puriﬁed RNA from NIH/3T3 or T24 cells pretreated with
ActD (50 ng/ml for 0.5 h, 4 h or 20 h) and rRNA tran-
scripts were monitored by hybridization to a 32P-labeled
riboprobe complementary to +1/+130 mouse or human
rRNA sequences. Northwestern analysis was performed
as described previously (36).
RESULTS
H2O2 treatment predominantly induces nucleolar PAR
formation
To investigate the localization and molecular mechanism
of PAR formation, T24 cells were treated with H2O2
(1mM for 10min). PAR formation was analysed by IF
using a 10H anti-PAR antibody and both conventional
and confocal ﬂuorescence microscopy. The PAR signal
was localized mainly to regions of the nucleus that were
stained weakly with DAPI, indicating that nucleoli are
sites of PAR formation (Figure 1A). The PAR signal in
T24 cells treated with H2O2 co-localized with ARTD1,
which suggests that ARTD1 is at least partly responsible
for PAR synthesis in response to oxidative stress in T24
cells (Figure 1B). Co-staining with anti-Pol I and anti-
ﬁbrillarin antibodies suggested partial co-localization
with the PAR signal (Figure 1C and D). Computerized
analysis of the acquired images revealed that 60–65% of
the ﬁbrillarin co-localized with a strong PAR signal
(Figure 1E). Similar levels of co-localization of ﬁbrillarin
with PAR signals were observed in H2O2-treated NIH/
3T3 (Figure 1D and E). H2O2-treated HeLa cells and
MEFs displayed a similar location of the PAR signal in
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Figure 1. H2O2 treatment induces nucleolar poly-ADP-ribose formation. Confocal immunoﬂuorescence microscopy of PAR (red) was performed
after H2O2 treatment (1mM, 10min). (A) Z-Stack-resolution of T24 cells, bar=10 mM. (B) Double-staining of T24 cells: PAR (red), ARTD1
(green), bar=10 mM. (C) Double-staining of T24 cells: PAR (red), RNA Pol 1 (green), bar=10 mM. (D) Double staining of T24 (upper row) and
3T3 (lower row) cells after H2O2 treatment (1mM, 10min): PAR (red) and ﬁbrillarin (green), bar=10 mM. (E) Quantiﬁcation of the co-localization
of the PAR signal and ﬁbrillarin staining in T24 and NIH/3T3 cells. (F) Confocal IF microscopy of PAR (red) after H2O2 treatment (1mM, 10min)
was analyzed in MEF and HeLa cells. Bar=10 mM.
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nucleoli (Figure 1F). Taken together, these results indicate
that the nucleoli are the main location of cellular PAR
formation during oxidative stress.
ActD treatment enhances nucleolar PAR formation on
H2O2 and MNNG stimulation
Although H2O2- and MNNG-induced PAR formation has
been attributed to DNA damage, a link between stress-
induced PAR synthesis and Pol I-dependent transcription
has not been documented previously. To investigate this
possibility, we pretreated cells for 20 h with a low dose of
ActD (50 ng/ml), which inhibits Pol I-dependent transcrip-
tion (38), before the exposure to H2O2 or MNNG.
Intriguingly, pretreatment with ActD followed by
exposure to H2O2 or MNNG increased both the number
of PAR-positive T24 cells and the intensity of the PAR
signal in comparison with cells not pretreated with ActD
(Figure 2A and B). A similar effect of ActD on the PAR
signal was also observed in cells ﬁxed with PFA, thus
excluding the possibility that the results obtained by the
methanol/acetic acid ﬁxation protocol were an artifact
(Supplementary Figure S1A, upper part).
In PFA-ﬁxed cells, PAR formation assessed by confocal
microscopy was also localized to DAPI-poor regions
(Supplementary Figure S1A, lower part). However, the
apparent extent of PAR and ﬁbrillarin co-localization in
PFA-ﬁxed cells was less than that in methanol/acetic acid-
ﬁxed cells. This discrepancy could be due to PFA ﬁxation
leading to masking of the epitope for antibody recogni-
tion, an observation that we also made for other nucleolar
proteins, which can only be detected in nucleoli when the
denaturating action of methanol ﬁxation is used (R.S.,
unpublished observation). ActD enhanced H2O2- or
MNNG-induced PAR formation also in NIH/3T3,
HeLa and MDA-MB-231 cells (Supplementary Figure
S1B–D), indicating that the observed ActD effect is bio-
logically conserved. ActD on its own did not induce PAR
formation, indicating that ActD caused increased PAR
formation by enhancing the signals induced by H2O2 or
MMNG. Furthermore, ActD did not alter localization of
PAR to nucleoli, as indicated by the unchanged co-
staining with ﬁbrillarin (Figure 2C and Supplementary
Figure S1D).
To analyze whether ActD-induced PAR formation was
due to the induction of cell death, cell viability was moni-
tored. ActD pretreatment with the low concentration of
50ng/ml did not signiﬁcantly affect cell viability, while
higher ActD concentrations (1mg/ml) strongly reduced
cell viability in T24 cells (Figure 2D). To exclude DNA
damage as the stimulus for PAR formation, the levels of
histone H2AX phosphorylation (gH2AX), a modiﬁcation
that occurs at sites ﬂanking DNA double-strand breaks
(DSBs) (39), were analyzed. Both of the positive controls,
the topoisomerase II inhibitor etoposide (50mM, 16h), as
well as high doses of ActD, induced gH2AX formation in
T24 cells (Figure 2E). We thus conclude that the strong
PAR signal induced by the pretreatment of T24 cells with
the low concentration of ActD (50ng/ml) was not due to
DNA damage or cell death. As PAR formation has previ-
ously been reported to occur under replicative stress (40),
we also analyzed the PAR signal as well as the gH2AX
formation in quiescent (G0 phase) T24 cells, on combined
ActD and H2O2, or ActD, etoposide and MNNG treat-
ment (Figure 2E and Supplementary Figure S2A).
Comparable with nonarrested cells, quiescent cells treated
with the low ActD concentration also displayed PAR for-
mation, but did not show induction of gH2AX, indicating
that enhanced PAR formation on ActD treatment does not
depend on replicative stress and cell proliferation.
We next tested whether enhanced PAR formation
depends on Pol I transcription. The analysis of 45S pre-
rRNA levels conﬁrmed that ActD was effective in
impairing pre-rRNA synthesis (>90%), while H2O2 or
MNNG reduced pre-rRNA levels only by 25–40%
under the tested conditions (Supplementary Figure S2B).
In contrast to ActD, pretreatment with the RNA Pol II
inhibitor a-amanitin did not induce PAR formation
(Supplementary Figure S2C), indicating that formation
of ActD-mediated PAR formation depends on RNA Pol
I transcription. Because PAR formation was inhibited by
Olaparib, an inhibitor of ARTDs including ARTD1 and
ARTD2 [Supplementary Figure S2D, (41)], ARTD1 and/
or ARTD2 could potentially be involved in the synergistic
effect between stress signaling and the interference of 45S
pre-rRNA synthesis for PAR accumulation in the
nucleolus.
ARTD2, but not ARTD1, is responsible for the
ActD-dependent enhancement of PAR formation
after H2O2 or MNNG treatment
To investigate whether ActD exerts its synergistic effect
through ARTD1 and/or ARTD2, T24 cells were
depleted of either ARTD1 or ARTD2 by siRNA
(Supplementary Figure S2E), pretreated with ActD as
indicated and PAR formation was induced by H2O2 or
MNNG. PAR formation was quantiﬁed by evaluating
the mean signal intensity of immunostained cells. PAR
levels were more strongly induced after H2O2 treatment
as compared with MNNG treatment (Figure 3A and B).
ActD pretreatment for 4 or 20 h enhanced the mean PAR
intensity per cell irrespective of whether H2O2 or MNNG
was used, while short pretreatment of only 30min had no
effect. This enhancement of PAR formation on ActD
treatment was more prominent in MNNG-treated cells
as compared with H2O2-treated cells under the tested con-
ditions (Figure 3B). Knockdown of ARTD1 almost com-
pletely abolished PAR formation in T24 cells treated with
H2O2, indicating that ARTD1 is responsible for most of
the H2O2-induced PAR formation (Figure 3C). However,
prolonged (4–20 h, 50 ng/ml) pretreatment of
ARTD1-silenced cells with ActD strongly enhanced
H2O2-induced PAR formation, despite the strong sus-
tained reduction of ARTD1 protein levels (Figure 3C).
These results indicate that the synergistic effect between
oxidative stress and the inhibition of 45S pre-rRNA
synthesis on PAR accumulation in the nucleolus is not
mediated by ARTD1. In contrast, compared with
siMOCK-treated cells, no additional increase in PAR
formation was observed after 4–20 h of ActD pretreat-
ment in ARTD2-depleted T24 cells (Figure 3C), indicating
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Figure 2. ActD treatment increases nuclear poly-ADP-ribose formation on H2O2 and MNNG stimulation. (A) Immunoﬂuorescence microscopy of
T24 cells was examined after H2O2 (1mM, 10min) and/or ActD treatment (50 ng/ml, 20 h) and stained for PAR formation (red).
(B) Immunoﬂuorescence microscopy of T24 cells after MNNG (500mM, 30min) and/or ActD treatment (50 ng/ml, 20 h) was examined.
(C) Quantiﬁcation of the co-localization of the PAR signal and ﬁbrillarin staining in T24 and NIH/3T3 cells pretreated with ActD. (D) Viability
assay (Alamar blue assay) of T24 cells treated with ActD (50 and 1000 ng/ml) for 4 h or 20 h [n=3, one-way analysis of variance (ANOVA),
followed by Tukey’s post hoc test]. (E) Immunoﬂuorescence microscopy of T24 cells stained for g-H2AX after ActD treatment (50 and 1000 ng/ml
for 20 h) and etoposide (50 mM for 16 h), either in cycling or in quiescent T24 cells.
Nucleic Acids Research, 2014, Vol. 42, No. 8 5077
that the stimulatory ActD effect on H2O2-induced PAR
formation was mainly regulated by ARTD2. The presence
of ARTD2, but not of ARTD1, also seemed to be respon-
sible for the increased PAR formation observed after co-
treatment of ActD and MNNG in T24 cells after 4 h
(Figure 3D). The slight, but not signiﬁcant, increase of
the PAR signal in cells pretreated with ActD for 20 h
and co-treated with MNNG may hint at the delayed and
attenuated stimulation of ARTD1, or an additional
ARTD family member that catalyzes additional PAR
formation under these conditions. H2O2 or MNNG
treatment in combination with ActD in NIH/3T3 cells
and subsequent quantiﬁcation of the PAR formation by
IF or visualization by western blot further conﬁrmed that
ARTD2 is responsible for the stimulatory ActD effect also
in mouse cells (Supplementary Figure S3A–H for H2O2 or
Supplementary Figure S4A and B for MNNG). Together,
these results indicate that ARTD2 is involved in PAR for-
mation in response to H2O2- or MNNG-treatment in
combination with ActD in T24 and NIH/3T3 cells.
ARTD2 activity is stimulated by rRNA in vitro
The described synergistic effect between ActD and H2O2/
MNNG on PAR formation could either be due to an in-
hibition of PAR degradation or a stimulation of PAR
synthesis. The former was studied by determining
whether ActD affects activity of the PARG, the primary
enzyme responsible for degrading protein-bound poly-
ADP-ribose (Figure 4A). In vitro 32P-labeled PARylated
ARTD1 was incubated with PARG in the presence of
ActD or rRNA, and PARylated ARTD1 levels were
monitored by autoradiography. Treatment with ActD or
rRNA did not prevent degradation of PAR moieties of
ARTD1, indicating that neither ActD nor rRNA affects
PARG activity.
The results described above indicate that H2O2 induces
PAR formation in the nucleoli (Figure 1). ActD impairs
45S pre-rRNA synthesis by preventing Pol I elongation
through the rDNA coding region and leads to an accumu-
lation of short RNA transcripts corresponding to se-
quences immediately downstream of the transcription
start site (+1/+130), as detected by northern blotting
(Figure 4B and Supplementary Figure S5A) (30,31). We
described above that only prolonged treatment with ActD
(4 and 20 h) enhanced formation of PAR in cells treated
with H2O2 or MNNG (Figure 3). Because PAR formation
correlated with the inhibition of 45S pre-rRNA synthesis
(Supplementary Figure S5B), we hypothesized that the
production of short rRNA transcripts induced by ActD
treatment might stimulate ARTD2 activity. To test this
hypothesis, we investigated the in vitro ARTD2
automodiﬁcation in the presence of in vitro synthesized
rRNA transcripts (corresponding to rDNA sequences
from 16 to +130 bp) using P32-labeled NAD+ to
monitor ADP-ribosylation (Figure 4C). Densitrometric
analysis of the incorporated radiolabeled ADP-ribose
revealed that the automodiﬁcation of ARTD2 was
stimulated by rRNA 3.4-fold stronger in comparison
with double-stranded DNA, while rRNA stimulated
ARTD1 only 0.7-fold compared with the stimulation
with double-stranded DNA (Figure 4C). This effect did
not seem to be mediated by speciﬁc rRNA sequences, as
other nonnucleolar RNA transcripts were able to stimu-
late ARTD2 activity to a similar extent (Supplementary
Figure S5C). In contrast to ARTD2, ARTD1 was strongly
activated by double-stranded DNA and, as previously
described (36), only exhibited 60% of its activity in the
presence of RNA as compared with DNA (Figure 4C).
Because the ActD effect was only observed in the
presence of genotoxic stress, we tested whether the activa-
tion of ARTD2 by RNA depends on double-stranded
DNA. Addition of DNA did not enhance the stimulatory
Figure 3. ARTD2 is responsible for the ActD-dependent increase in
poly-ADP-ribose formation. Quantitative PAR analysis of siMock-,
siARTD1- and siARTD2-treated T24 cells was performed after treat-
ment with ActD (50 ng/ml for 0.5, 4 and 20 h) and H2O2 (1mM,
10min) or MNNG treatment (500 mM, 30min). At least 100 cells
were analyzed per replicate (for 0.5 h; n=2 for siARDT1 and
siARTD2 samples, for other conditions n=3–5, one-way ANOVA
with Tukey’s post hoc test was performed). (A) siMock T24 cells
were treated with H2O2. (B) siMock T24 cells were treated with
MNNG. (C) H2O2 treated siARTD1 (left) and siARTD2 (right) T24
cells. (D) MNNG-treated siARTD1 (left) and siARTD2 (right) T24
cells. n.s.: P> 0.05; *P 0.05; **P 0.01; ***P 0.001.
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Figure 4. ARTD2 activity is stimulated by rRNA in vitro and binds to RNA via the SAP domain (A) In vitro radioactive PARG assay carried out
with in vitro modiﬁed ARTD1. PARG was added to each reaction in combination with pretreatment of ActD (50 ng/ml) or rRNA (146 nt). The
PARG reaction was performed for 15min at 4 C. Upper panel shows the autoradiography (32P) and the lower panel the corresponding coomassie
blue–stained gel (CB) of a representative experiment. Densitometric analysis of the radioactive signals was performed as described in M&M, and
values obtained are indicated at the bottom of the panel. The PARG untreated value was arbitrarily set to 1. (B) Northern blot analysis of NIH/3T3
cells treated with ActD (50 ng/ml for 0.5, 4 and 20 h). Hybridization was performed with a riboprobe corresponding to +1/+130 mouse rRNA
sequences. The lower panel shows 28S and 18S rRNA stained with ethidium bromide. (C) In vitro radioactive ARTD2 and ARTD1 activity assay
was performed with 100 ng NAD+ (32P) in the presence of in vitro transcribed rRNA piece (146 nt), DNA linker or ActD (50 ng/ml). CB =
coomassie blot. Densitometric analysis of the radioactive signals was performed as described in M&M and values obtained are included in the
result section. (D) In vitro radioactive ARTD2 activity assay was performed with 1.6 mM NAD+ (32P) and in vitro transcribed rRNA fragment
(146 nt) of different amounts (0.5, 5 and 10 pmol) and in presence or absence of 0.5 pmol DNA linker. Reaction was carried out at 30 C, 10min.
Densitometric analysis of the radioactive signals was performed as in panel A and values obtained are indicated at the bottom of the panel. The
untreated sample was arbitrarily set to 1. (E) In vitro radioactive ARTD2 activity assay with ARTD2 mutants was performed with 1.6 mM NAD+
(32P) in presence or absence of 5 pmol rRNA fragment (146 nt). FL/wt= full-length human ARTD2, ARDT2 SAP mutant 95–583 aa, ARTD2
SW mutant 231–583 aa, ARTD2 WGR mutant without WGR domain (deleted aa 116–193). Densitometric analysis of the radioactive signals
was performed as in panel (A) and values indicated at the bottom of the panel. The untreated wild-type sample was arbitrary set 1. (F) ARTD2 binds
to RNA via the SAP domain. Northwestern analysis. Membrane-bound recombinant wild type and the indicated ARTD2 mutants as well as ARTD1
(see coomassie-stained gel, CB) were incubated with radiolabeled rRNA (16 to +130) and bound RNA was visualized by autoradiography (32P).
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effect of RNA on ARTD2, conﬁrming that RNA stimu-
lates ARTD2 independent of DNA (Figure 4D).
ARTD2 binds to RNA through its SAP domain
To deﬁne which domain of ARTD2 is responsible for the
RNA-mediated activation, we compared the effect of
RNA on the activities of human ARTD2FL (full length)
and ARTD2SAP (aa 95–583), a mutant that lacks the
SAP domain and displays similar basal activity as
ARTD2FL. Although ARTD2FL was stimulated by
RNA, the deletion of the SAP domain impaired RNA-
mediated activation (Figure 4E). In addition to the loss
of the stimulation by RNA, the additional deletion of the
WGR domain (aa 231–583, ARTD2 SW), or removal of
the WGR domain alone (deletion of aa 116–193, ARTD2
WGR) resulted in a strong reduction of the general
ARTD2 activity (Figure 4E). RNA-binding experiments
with these proteins conﬁrmed that the SAP domain is re-
sponsible for the binding of ARTD2 to RNA. Together,
these results suggest that RNA is a potent activator of
ARTD2 enzymatic activity predominantly through the
SAP domain, and that the WGR domain is an important
structural element for the overall activity of the enzyme.
DISCUSSION
ADP-ribosylation has been implicated in several nucleolar
processes such as ribosome biogenesis, formation of
rDNA heterochromatin and stress sensing (32,34,36,42–
44). Here, we show that H2O2 or MNNG induces PAR
formation in the nucleoli of both mouse and human cells.
This is in agreement with previous studies that found
ARTD1 and ARTD2 to localize to nucleoli (34). The com-
bination of H2O2 or MNNG treatment with low doses of
ActD revealed a synergistic effect on PAR formation that
is mediated by ARTD2. It was well-known before that
ActD treatment leads to the accumulation of short
rRNA transcripts, which might be responsible for the en-
hancement of PAR formation. Short rRNA transcripts
were able to strongly stimulate ARTD2 activity via the
SAP/WGR domain, while double-stranded DNA did not
exhibit this effect. Our ﬁndings thus reveal a new activator
for ARTD2-dependent ADP-ribosylation, which has
important implications for the future analysis of the bio-
logical role of ARTD2 in the nucleus.
ADP-ribosylation and in particular the homologous
enzymes ARTD1 and ARTD2 have been traditionally
implicated in the response to DNA damage. An important
cornerstone for this model is the strong in vitro activation
of ARTD1 by double-stranded or nicked DNA, as well as
the detection of PAR on treatment of cells with genotoxic
compounds. In these DNA damage-dependent processes,
ARTD2 displays much less activity than ARTD1, raising
the question whether molecules other than activators of
ARTD1 activate ARTD2. Our results strongly suggest
that instead of binding to sites of DNA damage,
ARTD2 associates with RNA in the nucleolus, providing
an alternative cue to identify and respond to DNA
damage. In support of this, recent data have implicated
site-speciﬁc Dicer and Drosha RNA moieties in the
control of DNA damage (45). Furthermore, the activation
of ARTD2 by RNA may also be part of an intricate
network of RNA surveillance and repair mechanisms to
preserve RNA quality (46–48). The identiﬁcation of
ARTD2 activation by RNA is a new and unexpected
result that may indicate an additional mean for monitor-
ing not only genome integrity, but also other processes
speciﬁc for ARTD2. Genetic disruption of ARTD2, but
not of ARTD1, affects various differentiation processes in
mice, including spermatogenesis (49), adipogenesis (50)
and the survival of thymocytes (51).
Interestingly, the stimulation of ARTD2 in vivo was
dependent on the co-stimulation with ActD and H2O2 or
MNNG, indicating that additional signals induced by
H2O2 or MNNG are required for the activation of
ARTD2 by RNA. These signals might include the
damage of RNA, as oxidative damage in RNA is
usually higher than in DNA (52). However, our experi-
ments with H2O2-pretreated RNA did not strengthen this
hypothesis (data not shown). Alternatively, the treatment
of cells with H2O2 or MNNG might induce signaling
cascades that lead to the posttranslational modiﬁcation
of ARTD2, which is required for the stimulation with
RNA, besides damaging the DNA. Future studies of the
nucleolar ADP-ribose acceptors and the effect of ADP-
ribosylation on the response to RNA damage are needed
to reveal and deﬁne these functions in detail. Interestingly,
the ActD effect was observed in both human and mouse
cells, suggesting that the stimulation of ARTD2 is a bio-
logically conserved effect.
Under the study conditions described here, cellular
PAR formation on H2O2/MNNG treatment occurred to
a large portion within nucleoli. Growing evidence indi-
cates that the nucleolus plays a key role in monitoring
and responding to cellular stress. After exposure to
extra- or intracellular stress, signal pathways induce
rapid downregulation of 45S pre-rRNA synthesis that is
followed by perturbation of nucleolar structure, cell cycle
arrest and stabilization of p53 (53). The formation of high
levels of PAR in nucleoli under genotoxic stress conditions
might be part of this nucleolus-dependent signaling.
Whether PAR formation is due to a high accessibility of
nucleolar DNA and RNA to chemical agents and how this
occurs remains to be investigated.
Previous studies have shown that RNA is a key regula-
tor of ARTD1 in the nucleolus [(36) and Figure 4D/F].
Nucleolar localization of ARTD1 is dependent on RNA
and ARTD1 binds in vivo and in vitro to the nucleolar
noncoding pRNA, an intergenic transcript implicated in
the establishment of rDNA heterochromatin (54). pRNA
associates with the zinc ﬁnger DNA binding domain of
ARTD1 and stimulates ARTD1 activity, although to a
lesser degree than double-stranded DNA [(36) and
Figure 4D].
In this work, we provide evidence that RNA is a key
regulator of ARTD2 enzymatic activity. The nucleolar
localization of overexpressed ARTD2 has already been
described (34) and the currently available antibodies do
not permit a direct immunoﬂuorescent localization of
endogenous ARTD2 or determination of how RNA
affects nucleolar occupancy of ARTD2. However, we
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could demonstrate that RNA strongly activates ARTD2
activity. In contrast to ARTD1, double-stranded DNA
did not activate ARTD2. These ﬁndings suggest that the
structure and nature of nucleic acid is an important deter-
minant for the regulation of ARTD2 function. Consistent
with this, recent analyses with several DNA structures
mimicking intermediates of different DNA metabolizing
processes revealed that ARTD2 activation efﬁciency did
not correlate with K(d) values for DNA (55). ARTD2
displayed the highest afﬁnity for ﬂap-containing DNA,
but was more efﬁciently activated by 50-overhang DNA,
suggesting that single-stranded nucleic acids might be a
general stimulator of ARTD2. The stimulation did not
seem to be sequence-speciﬁc, as other RNAs tested were
also able to strongly stimulate ARTD2 (36). We have
identiﬁed SAP to be the main domain responsible for
the stimulation by RNA. The SAP motif (after SAF-A/
B, Acinus and PIAS) is a putative DNA/RNA binding
domain found in diverse nuclear and cytoplasmic
proteins (56,57). Based on the presented ﬁndings, it is
thus possible that other proteins with a SAP motif simi-
larly may bind RNA and be regulated by this binding.
Interestingly, deleting the WGR domain only abolished
the stimulation by RNA, but also the overall activity of
ARTD2, indicating that the structural arrangement of the
SAP and the CAT motif is functionally relevant.
Together, the strong activation of ARTD2 by RNA
through the SAP domain is a likely underlying cause for
the distinct and complementary functions mediated by this
homolog as compared with ARTD1. The fact that RNA
stimulates PAR formation by ARTD2 has not only mech-
anistic implications but also sheds new light on how
ARTD2 and poly-ADP-ribosylation function during the
genotoxic stress response.
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